- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT01937247
Redesigned Process in the Operating Room
Redesigned Process in the Operating Room: Monitoring and Evaluating Success of Reducing Non Operative Time
연구 개요
상태
상세 설명
The study aims to examine whether operating room efficiency will be improved by decreasing non operative time while ensuring patient safety.
Patients will be randomized into one of two groups:
In group A (new process): patients will be inducted in the induction room. At the end of surgery and after placement of the surgical dressing, the registered nurse will call in the house keeper to start cleaning of the OR (parallel processing) before the patient exits the room. The patient will be reversed with sugammadex 4mg/kg IV, and then extubated before being moved out of the OR. In group B (the current practice at AUBMC), patients will be treated as follows: patients will be induced in the operating room and at the end of surgery will be reversed with neostigmine 50µg/kg and glycopyrrolate 10µg/kg. Once extubated and rolled out of the room, the house keeper team will start cleaning the operating room. Induction time (IT), emergence time (ET), and turn over time (TOT) will be recorded for both groups.
We expect to show that OR efficiency will be improved by significantly decreasing non operative time while ensuring patient safety.
연구 유형
등록 (실제)
단계
- 2 단계
- 3단계
연락처 및 위치
연구 장소
-
-
-
Beirut, 레바논
- American University of Beirut Medical Center
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Patients, above 18 years of age, undergoing general surgery for surgeon X under general anesthesia
- Patients undergoing only the following general surgeries: laparoscopic hernia, laparoscopic appendectomy, laparoscopic cholecystectomy, and laparoscopic gastric/band sleeve surgeries
- American Society of Anesthesiologist Physical Status (ASA) I or II
- Research participant willing to sign informed written consent.
Exclusion Criteria:
- Patients under 18 years of age
- Patients undergoing general surgery for surgeon X under regional or spinal anesthesia
- Patients undergoing surgeries other than the following: laparoscopic hernia, laparoscopic appendectomy, laparoscopic cholecystectomy, and laparoscopic gastric/band sleeve surgeries
- American Society of Anesthesiologist Physical Status (ASA) III, IV, V, and VI
- Emergency and lifesaving Cases
- Inability or unwillingness of research participant or legal guardian/representative to give written informed consent.
- Inability to bring the next patient to the induction room for uncontrollable reasons such as failure of equipment, late arrival to the hospital, or late financial or medical clearance.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 지지 요법
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 네 배로
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
위약 비교기: Standard process
The control group is placebo group and this is our standard practice.
Patients will be induced in the operating room and at the end of surgery will be reversed with neostigmine 50µg/kg and glycopyrrolate 10µg/kg.
Once extubated and rolled out of the room, the house keeper team will start cleaning the operating room
|
standard process
|
|
활성 비교기: Redesigned process
Patients will be inducted in the induction room.
At the end of surgery and after placement of the surgical dressing, the registered nurse will call in the house keeper to start cleaning of the OR (parallel processing) before the patient exits the room.
The patient will be reversed with sugammadex 4mg/kg IV
|
The patients will be inducted in the induction room
The registered nurse will call in the house keeper to start cleaning of the OR (parallel processing) before the patient exits the room
The patient will be reversed with sugammadex 4mg/kg IV, and then extubated before being moved out of the OR
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Non-operative time
기간: within 24 hours of surgery
|
For Group A, non-operative time is defined as induction, emergence and turnover time For Group B, non-operative time is defined as turnover time
|
within 24 hours of surgery
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Satisfaction of the operation room staff and surgeons with the redesigned process
기간: within 24-48 hours after surgery
|
semi-structured individual interviews
|
within 24-48 hours after surgery
|
|
Patient satisfaction
기간: within 24-48 hours aftery surgery
|
Patient satisfaction survey
|
within 24-48 hours aftery surgery
|
|
Complication rate
기간: wihtin 24 hours of srugery
|
wihtin 24 hours of srugery
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Roland Kaddoum, MD, American University of Beirut Medical Center
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
Non-operative Time에 대한 임상 시험
-
Western University, Canada아직 모집하지 않음
-
Henan Cancer HospitalFundamenta Therapeutics, Ltd.아직 모집하지 않음Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited중국
-
Wael Elbanna ClinicFetal Medicine Research Center, Spain모병임신 여성: 1- ICSI-PGS 2- ICSI-non-PGS 3- 자연 임신 여성이집트
-
University Hospital, Strasbourg, France모병흉막 삼출액 | Thoracentesis를 수행하기 위한 Frist Time 표시 | 의대생 교육프랑스
-
UPECLIN HC FM Botucatu Unesp완전한
-
UPECLIN HC FM Botucatu Unesp완전한
-
Fundacion para la Investigacion Biomedica del Hospital...Fundación Mutua Madrileña완전한간세포 암 | 후천면역결핍증후군 바이러스 | 간염, 바이러스, Non-A, Non-B, 비경구적으로 전염됨스페인
-
Mayo Clinic모병
-
UPECLIN HC FM Botucatu Unesp알려지지 않은HIV 감염 | 후천성 면역 결핍 증후군 | 간염, 바이러스, Non-A, Non-B, 비경구적으로 전염됨브라질
-
Fundamenta Therapeutics, Ltd.The First Affiliated Hospital of Zhengzhou University아직 모집하지 않음Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited
STANDARD PROCESS에 대한 임상 시험
-
Konya City Hospital모병
-
Ospedale San Raffaele아직 모집하지 않음
-
Tanta University완전한수술 후 진통제 | 흉부 척추주위 블록 | 개방형 신장절제술 | Subtransverse interligamentary 블록이집트
-
Sophiahemmet UniversityKarolinska Institutet; Linnaeus University; The Swedish School of Sport and Health Sciences; Stockholm University모병
-
University of Oxford완전한
-
Nebraska Methodist Health SystemAcera Surgical, Inc.종료됨
-
Children's Hospital SrebrnjakBelupo; Podravka d.d.모병
-
Children's Hospital SrebrnjakBelupo; Podravka d.d.모병
-
Pfizer완전한성인 혈우병 B 피험자(FIX:C≤2%) 또는 성인 혈우병 A 피험자(FVIII:C≤1%)에서 현재 FVIII 예방 대체 요법의 전향적 효능 및 안전성 데이터를 평가하기 위한 연구혈우병 A | 혈우병 B미국, 캐나다, 스페인, 호주, 대만, 브라질, 일본, 독일, 영국, 사우디 아라비아, 프랑스, 벨기에, 그리스, 이탈리아, 대한민국, 터키 (Türkiye), 이스라엘, 스웨덴